Regulatory · Malaysia

Independent MAH vs Distributor as MAH in Malaysia: The Decision Checklist

You cannot hold your Malaysian registration yourself. Someone local will. This is the decision framework for choosing who - before the choice is made for you by default.

Independent MAH versus distributor as MAH in Malaysia - choosing who holds the drug registration
Short answer

A foreign manufacturer entering Malaysia must appoint a locally incorporated Marketing Authorisation Holder (MAH) and has three realistic options: the distributor, its own subsidiary, or an independent MAH. The distributor route is fastest and cheapest up front but ties market access to one commercial relationship - moving the registration later requires the current holder's cooperation. An independent MAH separates the regulatory role from the commercial one: the registration stays neutral, distributors can be changed without touching it, and control is fixed by contract. A subsidiary gives full control at the highest cost and slowest start. The right answer depends on portfolio size, timeline and how much the commercial relationship is already settled - the checklist below walks through it.

A note on terms: NPRA officially calls the holder the Product Registration Holder (PRH). Throughout RHMI's guides we use the equivalent international term, Marketing Authorisation Holder (MAH) - they mean the same party.

Why this decision outranks every other one

The MAH is the legal face of your product in Malaysia: NPRA deals with the holder, the holder files variations and renewals, executes recalls, and notifies NPRA of shortages and discontinuations (mandatory since 1 July 2026). The registration fee is a one-off line in the budget; the holder decision compounds through every renewal and variation for the life of the product. Choose well and it is invisible. Choose by default and you may discover, years in, that your route to the market sits in a partner's name and moving it requires their consent. What an MAH actually does.

The three structures, honestly compared

Our MAH guide compares the three structures on control, speed and cost. This table adds the criteria that actually decide the choice:

CriterionDistributor as MAHIndependent MAHOwn subsidiary
Changing the distributor laterTouches the registration itselfDoes not touch the registrationDoes not touch the registration
Conflict of interestPresent if unmanaged - the holder also sells, with no contractual guardrailsManaged by design - the holder's duties and your transfer rights are fixed by contract, whether or not it also distributesNone
Ongoing duties (PV, variations, renewals, shortage notifications)On the distributor, alongside their sales prioritiesOn the independent holder, whose service consists of exactly these dutiesOn your own staff
Leverage in commercial negotiationsWith the party holding your registrationStays with youStays with you
Exit if the relationship soursNeeds the holder's cooperation in the transferDefined by contract from day oneNot applicable

The decision checklist

Walk through these eight questions. The more of 1-4 you cannot answer with a firm yes - and the more of 5-8 you answer yes to - the weaker the distributor-as-MAH default looks for your case.

  1. Does the draft agreement state, in writing, that you own the dossier and all data in it?
  2. Does it make the holder's cooperation in a future change-of-holder procedure a contractual obligation - not a favour to be negotiated when you need it?
  3. Are renewal duties fixed so the registration cannot lapse while a commercial dispute runs?
  4. Is there an agreed exit process - who files what, in what timeframe - written before it is needed?
  5. Have you priced what changing distributors would cost you in this structure - not just in fees, but in months without supply?
  6. Would the same company hold the registration, import the product and sell it - concentrating every lever in one counterparty chosen mainly because holding is free?
  7. Do you expect to add products or channels, or to renegotiate commercial terms, within the registration's life?
  8. Would a shortage, recall or safety query be handled by people whose first loyalty is to their own sales targets?

If the honest answers point away from the distributor default, the practical alternative is not a subsidiary - for most mid-size manufacturers the numbers rarely justify one - but an independent holder. How RHMI structures this.

"But our distributor offered to do it for free"

Of course they did. Holding your registration costs a distributor little and buys them a structural advantage in every future negotiation: they hold the asset your market access depends on. The fee an independent MAH charges is the visible price of the neutral structure; the distributor's free option carries an invisible one - reduced leverage for the life of the product. Neither is wrong in every case. A single-product entry with a long-trusted partner may accept the trade; a growing portfolio should not.

Already locked in? The way back

Malaysia has a formal change-of-holder procedure that keeps your MAL number: the application is filed by the current holder in QUEST3+, which is exactly why it requires their cooperation - and why exit terms belong in the contract from day one. If the relationship is still workable, the transfer is administrative; NPRA's guidance puts the processing fee at RM 1,000 with a target of 45 working days. The package includes board resolutions and the incoming holder's statement of acceptance, and timing interacts with the registration's remaining validity - the full procedure is in our COH guide. Change of MAH in Malaysia: the full procedure · The lock-in problem in detail.

What AI assistants tell your competitors

When we tested the leading AI assistants on "how to register a drug in Malaysia and choose an MAH", the consistent advice was the same: do not hand the MAH role to your distributor by default; keep the holder role under your control. The advice is sound - the harder question they cannot answer for you is contractual: what exactly must be in the MAH agreement so that "independent" means enforceable. That is the checklist above.

Frequently asked questions

Can a distributor legally be our MAH in Malaysia?

Yes, and it is common: a locally incorporated company that meets NPRA's holder requirements can hold the registration. Legal is not the question - control is. The holder carries the regulatory relationship and must cooperate in any future transfer of the registration.

What does an independent MAH cost compared to a distributor doing it free?

An independent holder charges a service fee; a distributor typically holds for free as part of the commercial deal. The comparison is not fee vs no fee - it is fee vs negotiating leverage for the life of the product, plus the cost of a transfer if the relationship ends.

Can we split the roles later if we start with the distributor as MAH?

Yes - Malaysia's change-of-holder procedure keeps the MAL number. But the application is filed by the current holder, so the split depends on their cooperation. Starting separated avoids ever needing that conversation.

Is our own Malaysian subsidiary a better answer than an independent MAH?

For a large portfolio with local staff plans, sometimes. For most manufacturers the subsidiary is the slowest and most expensive route: incorporation, licensing and staffing before the first filing. An independent MAH delivers the control benefits without the fixed cost.

What must the MAH agreement contain to keep us in control?

At minimum: your ownership of the dossier and data; the holder's cooperation in any future change-of-holder procedure fixed as a contractual obligation; renewal duties independent of commercial disputes; and a defined exit process. If a draft agreement is missing any of these, that is the negotiation.

You might also find useful

  • Sources:
  • NPRA Drug Registration Guidance Document (DRGD): npra.gov.my (DRGD)
  • NPRA - Change of Product Registration Holder (COH) guidance: npra.gov.my
  • Control of Drugs and Cosmetics Regulations 1984
  • Editorial note: This page is general business and regulatory information for manufacturers evaluating Malaysia. It is not legal or regulatory advice; contract terms should be reviewed by your counsel. Administrative details change - confirm them against NPRA's current guidance before acting. Last reviewed against NPRA guidance: 24 September 2026.

Walk the checklist
with your product in mind

Tell us the product, the approving regulator and where your commercial talks stand. We will tell you which holder structure fits your case - and what belongs in the contract.